Temasek $800 million investment in Verily Life Sciences

26/1/2017

Financial investment

Value:

$ 800 million

Status:

Announced

Date:

26/1/2017

Overview:

Singaporean investment firm Temasek has made a $800 million investment in Verily Life Sciences.
Verily is the medical arm of Alphabet and was formerly known as Google Life Sciences.
Most of the proceeds will be made available to Verily immediately, with the remainder to follow shortly after.

Kurt Stumpo - Journalist

Jurisdictions:

United States
Singapore

Deal type:

Financial investment

Practice areas:

Private equity
M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Cleary Gottlieb Steen & Hamilton

Party: Alphabet (Seller)

Morrison & Foerster

Party: Temasek (Investor)

Lawyers: Alfredo Silva, Susan Mac Cormac

Sullivan & Cromwell

Party: Verily Life Sciences (Target)

Lawyer: Alison Ressler

Related deals